FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Original Application (SpecGx LLC)

View source ↗

Summary

FDA approved a methylphenidate hydrochloride extended-release generic from SpecGx LLC under an Original Application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

ORIG AP for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (METHYLPHENIDATE HYDROCHLORIDE)